Previous studies showed that female gender, history of diabetes mellitus, CKD stage, serum transferrin saturation, serum levels of ferritin and iPTH and angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blocking agent (ARB) were risk factors for severe anemia in CKD patients [15–19]. Here, ACE is linked to anemia.